COVID in California: Boosters targeting BA.5 subvariant approved by FDA
When COVID’s fall wave is expected to peak Officials with the Food and Drug Administration said Wednesday that a predicted...
Social Impact
Life expectancy in the U.S. dropped in 2021 for the second year in a row, but Covid deaths aren’t the only reason
U.S. life expectancy dropped for the second consecutive year in 2021, falling by nearly a year from 2020, according to...
FDA authorizes updated COVID boosters adapted for Omicron subvariants
The Biden administration's planned fall COVID-19 booster campaign cleared a key regulatory hurdle, after the Food and Drug Administration announced Wednesday...
Fauci on the U.S. COVID response: ‘There’s a lot that we need to do to improve’
With more than 1 million dead and the COVID-19 pandemic showing no signs of waning, the U.S. has experienced a...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/J3RWPV4JABJSPKPOODTIB6GTJA.jpg "China’s Guangzhou, Shenzhen tighten COVID curbs as parts of north join in")
China’s Guangzhou, Shenzhen tighten COVID curbs as parts of north join in
Workers set up barricades outside an entrance to the Wanxia urban village as part of coronavirus disease (COVID-19) control measures...
‘They got nothing:’ Distribution of COVID hazard pay to city workers raises objections | ClarksvilleNow.com
CLARKSVILLE, TN (CLARKSVILLE NOW) – Mike Ramey retired last year as a City of Clarksville employee during the height of...
Do You Really Need This New Omicron Booster? Here’s What Experts Say.
Sorry to break it to you, but COVID is still here — and likely to stick around indefinitely. What exactly...
FDA authorizes Covid booster shots that target omicron BA.5 variant
A medical staff prepares a booster dose of Pfizer's coronavirus disease (COVID-19) vaccine are seen at a vaccination centre in...
US clears updated COVID-19 boosters targeting newest omicron strain; shots could begin within days
WASHINGTON (AP) — The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most...
Immunosuppressive therapies for COVID-19 treatment
In a recent study published in the PLoS ONE journal, researchers assessed the impact of baricitinib, netakimab, and tocilizumab against...